A comparison of the effects of insulin-like growth factor-I, insulin and combined infusions of insulin and insulin-like growth factor-I on glucose metabolism in dogs. 1995

F Shojaee-Moradie, and A M Umpleby, and M J Thomason, and N C Jackson, and M A Boroujerdi, and P H Sönksen, and A Skottner, and R H Jones
Department of Medicine, UMDS, London, UK.

The effect of infusions of recombinant insulin-like growth factor-I (IGF-I) (34, 103 or 688 pmol kg-1 min-1), insulin (3.4, 10.3 or 68.8 pmol kg-1 min-1) or combined infusions (34 pmol IGF-I + 3.4 pmol kg-1 min-1 insulin or 103 pmol IGF-I + 3.4 pmol kg-1 min-1 insulin) on glucose metabolism was investigated in dogs using a [3-3H]-glucose infusion and euglycaemic clamp. All insulin doses decreased glucose production rate (Ra) in a dose-dependent manner (P < 0.05). All IGF-I doses decreased glucose Ra (P < 0.05) but this decrease was not dose dependent. The decrease in glucose Ra with the combined infusion of 34 pmol kg-1 min-1 IGF-I + 3.4 pmol kg-1 min-1 insulin was greater than 34 pmol kg-1 min-1 IGF-I (P < 0.05) but not different from 3-4 pmol kg-1 min-1 insulin. All insulin and IGF-I doses increased glucose utilization rate (Rd) in a dose-dependent manner (P < 0.01). The increase in glucose utilization was greater following both combined infusions than with either component infused alone (P < 0.05). Although at the doses selected, insulin and IGF-I had similar effects on glucose utilization with additive effects when the two peptides were combined, IGF-I was less effective than insulin in suppressing glucose production.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose

Related Publications

F Shojaee-Moradie, and A M Umpleby, and M J Thomason, and N C Jackson, and M A Boroujerdi, and P H Sönksen, and A Skottner, and R H Jones
October 1990, The American journal of physiology,
F Shojaee-Moradie, and A M Umpleby, and M J Thomason, and N C Jackson, and M A Boroujerdi, and P H Sönksen, and A Skottner, and R H Jones
May 1989, The Journal of clinical investigation,
F Shojaee-Moradie, and A M Umpleby, and M J Thomason, and N C Jackson, and M A Boroujerdi, and P H Sönksen, and A Skottner, and R H Jones
January 1992, The American journal of physiology,
F Shojaee-Moradie, and A M Umpleby, and M J Thomason, and N C Jackson, and M A Boroujerdi, and P H Sönksen, and A Skottner, and R H Jones
December 1997, The American journal of physiology,
F Shojaee-Moradie, and A M Umpleby, and M J Thomason, and N C Jackson, and M A Boroujerdi, and P H Sönksen, and A Skottner, and R H Jones
September 1989, The Journal of endocrinology,
F Shojaee-Moradie, and A M Umpleby, and M J Thomason, and N C Jackson, and M A Boroujerdi, and P H Sönksen, and A Skottner, and R H Jones
March 1999, Alcoholism, clinical and experimental research,
F Shojaee-Moradie, and A M Umpleby, and M J Thomason, and N C Jackson, and M A Boroujerdi, and P H Sönksen, and A Skottner, and R H Jones
June 1992, The Journal of clinical investigation,
F Shojaee-Moradie, and A M Umpleby, and M J Thomason, and N C Jackson, and M A Boroujerdi, and P H Sönksen, and A Skottner, and R H Jones
November 1995, The Journal of surgical research,
F Shojaee-Moradie, and A M Umpleby, and M J Thomason, and N C Jackson, and M A Boroujerdi, and P H Sönksen, and A Skottner, and R H Jones
January 2010, Journal of pediatric endocrinology & metabolism : JPEM,
F Shojaee-Moradie, and A M Umpleby, and M J Thomason, and N C Jackson, and M A Boroujerdi, and P H Sönksen, and A Skottner, and R H Jones
October 1993, The Journal of clinical investigation,
Copied contents to your clipboard!